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Precise assessment of left ventricular (LV) contractility dur-
ing veno-arterial extracorporeal membrane oxygenation 
(VA-ECMO) support is crucial. However, changes in loading 
conditions may mask changes in LV function when assessed 
with load-dependent parameters. We compared end-systolic 
elastance (Ees, mm Hg/ml), the reference load-independent 
parameter of LV contractility, with LV ejection fraction (LVEF) 
in two patients. The first patient was a 54-year-old patient 
supported with femoro-femoral VA-ECMO for a cardiogenic 
shock. Afterload was calculated by using arterial elastance 
(Ea, mm Hg/ml). Although Ees near doubled from day 0 to 
day 3, no significant change was observed in LVEF. The sec-
ond patient was a 61-year-old patient supported with femoro-
femoral VA-ECMO for severe heart failure complicated with 
sepsis. We retrospectively showed that discrepancy between 
LVEF and Ees resulted from changes in LV-arterial coupling. 
We concluded that LVEF may be misleading in the assessment 
of LV function during VA-ECMO for heart failure. ASAIO 
Journal 2017; XX:00–00.
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Peripheral veno-arterial extracorporeal membrane oxygen-
ation (VA-ECMO) is now the first-line device for refractory 
acute cardiogenic shock. Veno-arterial extracorporeal mem-
brane oxygenation system pumps venous blood from the right 
atrium and reinjects oxygenated blood countercurrent into the 
descending aorta. Precise evaluation of left ventricular (LV) 
function in patients under assistance is a key point, in particu-
lar during weaning, and largely based on LV ejection fraction 
(LVEF).1 However, the use of this load-dependent parameter 
is questionable. Indeed, more than 25 years ago, Robotham 
et al.2,3 already pointed out that LVEF reflects the coupling 
between LV contractility and LV afterload but not the LV intrin-
sic contractility.
Case Reports
A 54-year-old man presented a cardiogenic shock in relation 
with a stunned myocardium after coronary artery by-pass. He 
was supported with femoro-femoral VA-ECMO as a bridge to 
recovery (or transplantation). After 3 days, because we observed 
a normalization of blood lactates, an improvement in hemody-
namics, and a normalization of liver and renal functions, the 
question of ECMO weaning was raised. We compared LVEF 
with end-systolic elastance (Ees), the reference parameter of LV 
contractility, known to be independent of loading conditions. 
End-systolic elastance was calculated as Ees = ESP/(ESV − Vo), 
where Vo is the intercept of end-systolic pressure–volume 
(ESPV) line with the x-axis, ESP is LV end-systolic pressure and 
ESV is LV end-systolic volume. Ees corresponds to the slope of 
the ESPV relationship (ESPVR) (Figure 1). Left ventricular sys-
tolic pressure was derived from femoral arterial line, whereas 
ESV was derived from transthoracic 2D echocardiography with 
automated border detection (VIVID S6; GE Healthcare). Arte-
rial line was placed in contralateral femoral artery to cannu-
lation site, far downstream from the VA-ECMO injection, in 
such a way that aortic pressure at the end-systole was equili-
brated with LV ESP. The dicrotic arterial pressure and the cor-
responding ESV were plotted to determine one point of ESPVR 
in the pressure–volume (PV) graph. Several points of ESPVR 
were determined by changing pump speed, which resulted 
in load variation. Stroke volume (SV) was calculated as (EDV 
− ESV), where EDV is LV end-diastolic volume and LVEF (%) 
was calculated as SV/EDV. The afterload imposed to the left 
ventricle was also described by an arterial elastance (Ea) (mm 
Hg/ml), characterizing arterial properties including wall stiff-
ness, compliance, outflow resistance, and wave’s reflections.4 
Arterial elastance (mm Hg/ml) was calculated as the ratio of 
ESP to SV. Basal recordings were performed at day 0, and a 
new set of measurements was performed in the same manner 
described previously at day 3. Results are depicted in Table 1 
and Figure 2. Compared with measurements performed at day 
0, LVEF and SV slightly decreased by 3% and 7 ml at day 3. 
However, Ees increased from 0.51 to 1.09 mm Hg/ml, and Ea 
increased from 2.63 to 4.45 mm Hg/ml, leading to a worsening 
of LV-arterial coupling. Mean arterial pressure (MAP) increased 
by 18 mm Hg, whereas heart rate (HR) did not significantly 
change. Unfortunately, during the night between day 3 and 
day 4, although heart function was improving and weaning 
was discussed, the patient presented a bleeding diathesis and 
evolved to a multiple organ failure and died.
A 61-year-old man was admitted in intensive care unit (ICU) 
for severe heart failure. He presented tachycardia-induced 
cardiomyopathy with severe dyspnea, signs of poor tissue 
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perfusion, and moderate hypotension. Echocardiography 
demonstrated low LVEF (9%) and aortic velocity time integral 
(8.1 cm). Despite effective antiarrhythmic therapy, there was 
no improvement neither in aortic flow nor in LVEF, and the 
patient was rapidly supported with VA-ECMO. Hypotension 
was enhanced by vasoplegia resulting from pulmonary sepsis 
with MAP = 56 mm Hg despite vasopressor treatment. After 
empirical antibiotic treatment, vasopressors were weaned 
after 3 days, and the patient paradoxically developed sys-
temic hypertension with MAP reaching 126 mm Hg. How-
ever, echocardiography did not show any improvement in 
LVEF while vasopressors were weaned. When antihyperten-
sive drugs (i.e., vasodilators) were administrated, a significant 
increase in LVEF (28% vs. 9%) was observed. Veno-arterial 
extracorporeal membrane oxygenation was weaned at day 4 
and outcome was favorable: LVEF increased to 34 % when 
VA-ECMO was removed. The patient left ICU a few days 
later. In this second case report, we retrospectively analyzed 
LV-arterial coupling by considering Vo = 0 ml because VA-
ECMO flow was not changed intentionally to precisely deter-
mine Ees. In these circumstances, an approximation of Ees 
(Ees′) was simply given by ESP-to-ESV ratio. Between day 0 
Figure 1. Schematic representation of LV P-V loop: SV is given by the intersection between ESPVR and Ea line. Ees is the slope of ESPVR; 
ESP is given by arterial pressure (at the dicrotic notch). V0, dead volume; ESV, end-systolic volume; EDV, end-diastolic volume; LV P-V, left 
ventricular pressure–volume; SV, stroke volume; ESPVR, end-systolic pressure–volume relationship; Ea, arterial elastance; Ees, end-systolic 
elastance; ESP, end-systolic pressure.
Table 1.  Catecholamine Levels, ECMO Flow, and Hemody-
namic Parameters at Days 0 and 3
 Day 0 Day 3
Dobutamine (µg/kg/min) 5 5
Norepinephrine (µg/kg/min) 5 15
ECMO flow (L/min) 5.80 5.50
MAP (mm Hg) 71 89
HR (bpm) 86 88
SV (mL) 27 20
LVEF (%) 17 14
LVEDV (mL) 156 137
LVESV (mL) 129 127
Ees (mm Hg/mL) 0.51 1.09
Ea (mm Hg/mL) 2.63 4.45
Ees/Ea 0.33 0.24
MAP, mean arterial pressure; HR, heart rate, SV, stroke vol-
ume; LVEF, left ventricular ejection fraction; LVEDV, left ventricular 
end-diastolic volume; LVESV, left ventricular end-systolic volume; 
Ees, end-systolic elastance; Ea, arterial elastance; Ees/Ea, ven-
triculo-arterial coupling index; ECMO, extracorporeal membrane 
oxygenation.
Figure 2. Schematic representation of LV P-V loop at day 0 (solid 
line) and at day 3 (dotted line): SV decreased while contractility Ees 
increased because Ea increased. LV P-V, left ventricular pressure–
volume; SV, stroke volume; Ees, end-systolic elastance; Ea, arterial 
elastance.
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and day 3, Ees′ increased from 0.46 to 0.86 mm Hg/ml and 
Ea increased from 4.66 to 6.24 mm Hg/ml when vasoplegia 
was ruled out. As a result, Ees′-to-Ea ratio did not significantly 
change (0.11 vs. 0.14). When vasodilators were adminis-
trated, Ea decreased to 2.24 mm Hg/ml, whereas Ees′ did not 
changed, leading to an improvement in LV-arterial coupling, 
with Ees′-to-Ea ratio = 0.41 (Table 2).
Discussion
Assessment of LV function during VA-ECMO is mainly based 
on LVEF. However, it is well established that LVEF is the result 
of a continuous interaction between LV intrinsic contractility 
and afterload (Figure 1). During assistance, when aortic valve 
opens, SV is transferred into the aorta against arterial load 
which is the combination of arterial tone and injection from 
the VA-ECMO pump. As LV volume decreases from EDV to 
ESV, the actual ESV is a function of not only intrinsic heart 
contractility, but also of this arterial load. For the same EDV 
and intrinsic heart contractility, if arterial pressure at end-
systole decreases (i.e., Ea decreases), then ESV is lower and 
LVEF greater (Figure 1). Reversely, increasing arterial pressure 
(i.e., increasing Ea) has the opposite effect by increasing ESV 
and decreasing LVEF. This is even more significant when LV 
contractility is low. Indeed, the lowest the slope of ESPVR, the 
greatest the influence of afterload on SV and LVEF (Figure 2). 
Importantly, if arterial load is independently varied (e.g., by 
changing VA-ECMO flow), the ESPVR can be easily deter-
mined. The slope of the ESPVR (Ees) precisely determines the 
intrinsic contractility of the heart (Figure 1). The steeper the 
slope, the greater the contractility. Ees (mm Hg/ml) is a use-
ful, load-independent index of myocardial contractility. Ees 
is the reference measure of LV systolic performance derived 
from the complex association between the inotropic efficiency 
and the functional, structural, and geometric characteristics 
of the left ventricle. This case report clearly demonstrates dis-
crepancy between LVEF and contractility which may lead to 
improper assessment of LV function, when using load-depen-
dent parameters. Current recommendations for VA-ECMO 
weaning consider that VA-ECMO could be withdrawn when 
LVEF is > 20% at minimal VA-ECMO flow. However, in addi-
tion to VA-ECMO flow, others components of Ea (like vascular 
tone) can also mask change in LV contractility. In our case, 
afterload was severely increased at day 3, because of vasopres-
sors. This was responsible for a severe increase in Ea, leading to 
a drop in LVEF while LV contractility increased (Figure 2). Simi-
larly, the same mechanism applies in sepsis when vasoplegia 
is corrected, resulting in a decrease in LVEF while LV contrac-
tility has not changed.3,5 This is well illustrated in the second 
case report; LVEF did not change while “estimated” Ees (Ees′) 
increased at day 3, when vasoplegia was corrected. Ees’-to-Ea 
ratio (LV-arterial coupling index) did not significantly change 
because of increased Ea resulting from vasoplegia correction 
and hypertension. As LVEF is the result of LV-arterial coupling, 
no improvement was observed, based on LVEF assessment. 
When Ea decreased, resulting from vasodilators administra-
tion, LV-arterial coupling improved (Ees′-to-Ea ratio increased) 
and finally LVEF increased (Figure 3). Interestingly, this “load 
sensitivity” is enhanced in failing hearts because the slope of 
the end-systolic line (Ees) is lower than in normal hearts. After-
load burden induced by VA-ECMO injection is responsible 
for worsening of LV-arterial uncoupling, leading to impaired 
energetic efficiency and increased oxygen consumption by 
the myocardium.6 As a result, determination of weaning time 
is crucial, and assistance should only be left in place while 
the heart is unable to achieve adequate blood flow. In such 
a way, other devices (e.g., Impella or CentriMag) may be pre-
ferred in circumstances where recovery is an option specifi-
cally because they do not impose such an afterload burden. In 
fact, weaning protocols, by turning down the VA-ECMO flow, 
intuitively improve ventriculo-arterial coupling and determine 
whether its result (i.e., SV) is adequate. However, as shown in 
the last discussion, these weaning tests are strongly influenced 
by loading conditions.
In conclusion, these two case reports clearly show that LV-
arterial coupling is a key factor when assessing LV function in 
heart failure and that focusing only on load-dependent param-
eters can lead to improper assessment of LV function. Discrep-
ancy between LVEF and contractility, which may at first appear 
paradoxical, is well explained by LV PV analysis.Table 2.  Catecholamine Levels, ECMO Flow, and Hemody-
namic Parameters at Days 0, 3, and 4
 Day 0 Day 3 Day 4
Norepinephrine (µg/kg/min) 0.8 0 0
Isosorbide dinitrate (mg/h) 0 0 4
ECMO flow (L/min) 5.1 4.8 4.6
SAP (mm Hg) 56 126 84
MAP (mm Hg) 56 126 84
HR (bpm) 109 86 93
SV (mL) 19 25 56
LVEF (%) 9 12 28
LVEDV (mL) 199 206 202
LVESV (mL) 181 177 138
Ees (mm Hg/mL) 0.47 0.87 0.91
Ea (mm Hg/mL) 4.66 6.24 2.24
Ees/Ea 0.11 0.14 0.41
MAP, mean arterial pressure; HR, heart rate, SV, stroke vol-
ume; LVEF, left ventricular ejection fraction; LVEDV, left ventricular 
end-diastolic volume; LVESV, left ventricular end-systolic volume; 
Ees, end-systolic elastance; Ea, arterial elastance; Ees/Ea, ven-
triculo-arterial coupling index; ECMO, extracorporeal membrane 
oxygenation.
Figure 3. Schematic representation of LV P-V loop. Although 
“estimated” Ees ((Ees′) did not change, SV and consequently ejec-
tion fraction varied as a function of Ea. LV P-V, left ventricular pres-
sure–volume; Ees, end-systolic elastance; SV, stroke volume; Ea, 
arterial elastance.
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